BioConst生物常量

BioConst

Proteostasis Fails as a Quality-Control Stack

Research Note: Proteostasis Fails as a Quality-Control Stack

This is a research discussion, not medical advice. BioConst does not recommend supplements, drugs, fasting protocols, or any personal intervention from this note.

Question

Protein quality control is easy to name and hard to measure. Proteostasis includes folding, refolding, degradation, organelle cleanup, and stress response. BioConst needs a tracker view that asks which part of the stack failed before it asks what might be done.

Source-Backed Data Points

  • The 2023 expanded hallmarks framework lists both loss of proteostasis and disabled macroautophagy among 12 hallmarks of aging. Source: PubMed 36599349.
  • A proteostasis review defines the network around molecular chaperones, the ubiquitin-proteasome system, and autophagy. Source: PubMed 32456366.
  • A 2024 autophagy review describes macroautophagy as a recycling process that degrades cytoplasmic components including protein aggregates and mitochondria, and summarizes age-dependent changes across pathway steps. Source: PubMed 39195254.

Reading

The important distinction is between a waste problem and a control problem. A cell does not only need fewer damaged proteins. It needs sensing, triage, transport, lysosomal function, proteasome capacity, and stress-response coordination. A note that says "proteostasis support" without naming which layer is being measured has not yet become evidence.

Macroautophagy also deserves its own tag. In the 2023 hallmarks update it is not merely hidden under generic proteostasis. That means BioConst should track it separately when a source discusses autophagosome formation, lysosomal fusion, mitophagy, or lysosomal function.

Tracker Rule

BioConst will split proteostasis entries into chaperone response, proteasome degradation, macroautophagy, mitophagy, and lysosomal function. Framework-level papers can define the map, but intervention entries need a concrete measurement: aggregate burden, proteasome activity, autophagic flux, lysosomal markers, or a functional endpoint.